Study finds improved survival for incurable brain tumor, providing 'a crack in the armor'

byUniversity of MichiganA series of brain scans shows a tumor shrinking in response to ONC201. Credit: Michigan MedicineFor the first time, researchers have found a potential drug candidate that

Updated on: January 23,2024 11

Study finds improved survival for incurable brain tumor, providing 'a crack in the armor'

byUniversity of MichiganA series of brain scans shows a tumor shrinking in response to ONC201. Credit: Michigan MedicineFor the first time, researchers have found a potential drug candidate that

Updated on:January 23,2024 11

Mathematical modeling leads to a better understanding of prostate cancer

by Eva Schissler,University of CologneCredit:Cell Systems(2024). DOI: 10.1016/j.cels.2024.10.005A team led by Dr. Yuri Tolkach at the University of Cologne's Faculty of Medicine

Updated on: December 01,2024 0

Mathematical modeling leads to a better understanding of prostate cancer

by Eva Schissler,University of CologneCredit:Cell Systems(2024). DOI: 10.1016/j.cels.2024.10.005A team led by Dr. Yuri Tolkach at the University of Cologne's Faculty of Medicine

Updated on:December 01,2024 0

Researchers report results in rare gynecologic cancers from DART immunotherapy trial

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainResults from the S1609 DART clinical trial, which tested an immunotherapy combination of ipilimumab plus nivolumab in 53 cohorts of pat

Updated on: February 03,2024 18

Researchers report results in rare gynecologic cancers from DART immunotherapy trial

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainResults from the S1609 DART clinical trial, which tested an immunotherapy combination of ipilimumab plus nivolumab in 53 cohorts of pat

Updated on:February 03,2024 18

Increased risk of prostate cancer in men with BRCA2 gene fault

by Cancer Research UKCredit: CC0 Public DomainMen with the BRCA2 gene fault have an increased risk of prostate cancer and could benefit from PSA (prostate specific antigen) testing to help detect

Updated on: May 09,2024 6

Increased risk of prostate cancer in men with BRCA2 gene fault

by Cancer Research UKCredit: CC0 Public DomainMen with the BRCA2 gene fault have an increased risk of prostate cancer and could benefit from PSA (prostate specific antigen) testing to help detect

Updated on:May 09,2024 6

New PET/MRI probe promises early discovery of covert diseases

byInstitute of Organic Chemistry and Biochemistry of the CASCurrent PET/MRI imaging of healthy and damaged mouse kidneys using the dual contrast agent [18F][Gd(FL1)]. The imaging provides consis

Updated on: September 15,2024 0

New PET/MRI probe promises early discovery of covert diseases

byInstitute of Organic Chemistry and Biochemistry of the CASCurrent PET/MRI imaging of healthy and damaged mouse kidneys using the dual contrast agent [18F][Gd(FL1)]. The imaging provides consis

Updated on:September 15,2024 0

Active surveillance feasible for low-risk thyroid cancer

Active surveillance may be a viable strategy for most diagnosed thyroid cancers, according to a study published online Sept. 15 inJAMA Oncology.Allen S. Ho, M.D., from Cedars-Sinai Medical Cente

Updated on: January 21,2024 10

Active surveillance feasible for low-risk thyroid cancer

Active surveillance may be a viable strategy for most diagnosed thyroid cancers, according to a study published online Sept. 15 inJAMA Oncology.Allen S. Ho, M.D., from Cedars-Sinai Medical Cente

Updated on:January 21,2024 10

Tumor heterogeneity and immune-evasive environment in malignant lymphoma at single-cell resolution

byUniversity of TsukubaTranscriptomic profile of T follicular helper cell lymphoma (TFHL) samples. Credit:Leukemia(2023). DOI: 10.1038/s41375-023-02093-7Researchers at the University

Updated on: January 26,2024 22

Tumor heterogeneity and immune-evasive environment in malignant lymphoma at single-cell resolution

byUniversity of TsukubaTranscriptomic profile of T follicular helper cell lymphoma (TFHL) samples. Credit:Leukemia(2023). DOI: 10.1038/s41375-023-02093-7Researchers at the University

Updated on:January 26,2024 22

Study suggests lung cancer does not decrease in line with reduced smoking

byUmea UniversityIncidence rates for lung cancer according to age, sex and time (cases/100,000 person-years). Notice the different scales on the vertical axes (incidence rates). Credit:Eur

Updated on: April 06,2024 0

Study suggests lung cancer does not decrease in line with reduced smoking

byUmea UniversityIncidence rates for lung cancer according to age, sex and time (cases/100,000 person-years). Notice the different scales on the vertical axes (incidence rates). Credit:Eur

Updated on:April 06,2024 0

Novel late-stage colorectal cancer treatment proves effective in preclinical models

by Angel Mendez,University of Minnesota Medical SchoolThe low T cells are due to exosomal, immunosuppressive miRNAs that disrupt T cell function and loss of T cells in the tumor environment. Cre

Updated on: April 29,2024 13

Novel late-stage colorectal cancer treatment proves effective in preclinical models

by Angel Mendez,University of Minnesota Medical SchoolThe low T cells are due to exosomal, immunosuppressive miRNAs that disrupt T cell function and loss of T cells in the tumor environment. Cre

Updated on:April 29,2024 13

Researchers zero in on molecular fingerprint for prostate cancer

by University of South AustraliaCredit: University of South AustraliaSix cancers that claim more than 23,000 Australian lives each year1 should be prioritised for research that makes it possible

Updated on: March 12,2024 20

Researchers zero in on molecular fingerprint for prostate cancer

by University of South AustraliaCredit: University of South AustraliaSix cancers that claim more than 23,000 Australian lives each year1 should be prioritised for research that makes it possible

Updated on:March 12,2024 20

Team identifies how certain immune cells contribute to worse survival rates in HER2-positive breast cancer patients

by European Organisation for Research and Treatment of CancerCredit: Unsplash/CC0 Public DomainPatients with a type of breast cancer called HER2-positive are less likely to survive if their initial tr

Updated on: February 24,2024 12

Team identifies how certain immune cells contribute to worse survival rates in HER2-positive breast cancer patients

by European Organisation for Research and Treatment of CancerCredit: Unsplash/CC0 Public DomainPatients with a type of breast cancer called HER2-positive are less likely to survive if their initial tr

Updated on:February 24,2024 12

New drug delays progression of glioma, a deadly brain cancer, during clinical trial

by Denise Heady,University of California, Los AngelesCredit: Unsplash/CC0 Public DomainIn an international study co-led by UCLA, scientists have shown that a new targeted therapy drug can extend

Updated on: January 15,2024 18

New drug delays progression of glioma, a deadly brain cancer, during clinical trial

by Denise Heady,University of California, Los AngelesCredit: Unsplash/CC0 Public DomainIn an international study co-led by UCLA, scientists have shown that a new targeted therapy drug can extend

Updated on:January 15,2024 18